Background. The urinary tract is the most common source for Escherichia coli bacteremia. Mortality from E. coli urinary-source bacteremia is higher than that from urinary tract infection. Predisposing factors for urinarysource E. coli bacteremia are poorly characterized.
The urinary tract is the most common source of systemic Escherichia coli infection. Escherichia coli bacteremia is associated with a mortality rate of 5%-21% [1, 2] . Antimicrobial-resistant isolates can result in mortality rates as high as 61% [3] . Approximately 36 000 deaths occur in the United States annually from E. coli bacteremia [4] .
Multiple studies have attempted to determine risk factors for the progression from E. coli urinary tract infection (UTI) to urinary-source bacteremia (USB) [5] [6] [7] [8] [9] [10] [11] . However, most were limited to communityacquired UTIs [5] [6] [7] 11] or female patients [5, 7] or were conducted retrospectively [8, 10] . In addition, not all studies described if they used UTI patients with negative blood cultures for comparison [9, 10] . Only 1 study had .100 patients: Velasco et al conducted a prospective study of 669 community-acquired infections [11] . The only consistent, clinical risk factor that emerged from these studies was advanced patient age [5-7, 10, 11] . However, clinical factors are not the only determinant of risk of bacteremia; the inherent virulence of the microorganism may also play a role. Previous studies have reported inconsistent associations with specific bacterial virulence factors and were limited by small sample sizes [5] [6] [7] [8] [9] [10] , with a maximum of 100 subjects [8] .
Our study objective was to identify host and pathogen risk factors for E. coli USB in a large, inclusive population. Our longterm goal is to contribute to the clinical decision making for hospital patients with UTIs and to help improve outcomes. Identification of novel risk factors could contribute to predictive models that facilitate early recognition of high-risk patients.
METHODS

Study Design, Data Collection, and Definitions
We conducted a prospective cohort study of patients with E. coli bacteriuria from 1 August 2009 until 31 July 2010 at BarnesJewish Hospital, a 1250-bed teaching hospital in Missouri. All adult patients admitted to Barnes-Jewish Hospital who presented with or developed E. coli bacteriuria during their hospital stay and had blood cultures taken at time of bacteriuria were eligible for enrollment. Patients with polymicrobial UTIs and/or concurrent bloodstream infection with an organism other than E. coli were excluded. Medical records of those who met inclusion criteria were reviewed for demographics and medical/ urogenital history. Charlson comorbidity and McCabe severityof-illness scores were computed. The patients' clinical presentation; vital signs; and laboratory, radiological, and pharmacy data were prospectively reviewed during the admission. For each antibiotic with gram-negative activity, the start and stop times were recorded.
The primary outcome was development of E. coli bacteremia. Blood cultures were drawn at the discretion of the treating physicians and had to occur within 6 1 day of the positive urine culture. Given that urine and blood specimens were processed almost simultaneously, the primary outcome was determined within 1 day of enrollment. Secondary outcomes were sepsis, sepsis-induced hypotension, transfer to the intensive care unit (ICU) within 3 days, length of hospital stay after detection of bacteriuria, and in-hospital mortality. At the time of the study, the cutoff for significant bacteriuria used by the hospital microbiology laboratory was 5 3 10 4 colony-forming units (CFU)/mL in noncatheterized patients and 5 3 10 3 CFU/mL in catheterized patients. Bacteriuria was classified as communityacquired if the first positive urine culture occurred #48 hours after admission. Bacteriuria was classified using the patients' documented urinary symptoms. Asymptomatic bacteriuria was defined as absence of urinary symptoms and/or fever; cystitis was defined as presence of dysuria, frequency, or urinary retention/hesitancy (without signs of pyelonephritis) [12] ; pyelonephritis was defined as presence of flank pain or tenderness and/or fever; and unclassified bacteriuria was defined as bacteriuria in a patient who did not fit any of the above criteria and could not report symptoms (eg, intubation, altered mental status). The bacteriuria was considered to be catheter-associated if a urinary catheter had been in place in the 48 hours prior to the positive urine culture; the same classification criteria as above were used. Past urogenital surgery included all surgeries that resulted in anatomical alteration (eg, nephrectomy, neobladder formation, hysterectomy, prostate resection). Sepsis and sepsisinduced hypotension were defined using established criteria [13] . Adequacy of antibiotic therapy was defined as pathogendirected treatment with matching antibiotic susceptibilities.
Laboratory Analyses
We identified the E. coli isolates from urine cultures of eligible patients in the hospital microbiology laboratory and stored them at 280°C in skim milk. The isolate collection was shipped to the Molecular and Clinical Epidemiology Laboratory at the School of Public Health, University of Michigan, Ann Arbor, for further processing. Bacterial DNA was extracted using QIAamp DNA mini kit (Qiagen, Valencia, California). DNA probes for virulence genes were designed as previously described [14] [15] [16] [17] [18] ( Table 1 ). The presence of these virulence genes was determined by dot-blot hybridization with fluorescent-labeled probes and a fluorescein-based detection system as described elsewhere [19] . To screen large numbers of isolates in short time periods, we used a microarray system for high-throughput hybridization [20, 21] . The frequency of specific virulence genes was compared between the urine isolates of bacteremic and nonbacteremic patients (ie, bacteriuria with negative blood cultures). Bacterial isolates were compared regarding antimicrobial susceptibility patterns obtained using disk diffusion tests.
Sample Size Calculations and Statistical Analysis
We assumed that there would be 15% bacteremic vs 85% nonbacteremic cases [5] . Based on data regarding the papGiA2 genotype (a virulence gene associated with E. coli bacteremia in an earlier study) [6] , we estimated that bacteremic E. coli will carry prf (P-related fimbriae, a previously described marker for a variety of P-fimbriae [22] ) in 70% of cases and nonbacteremic E. coli in 35%. To determine a difference at the .05 significance level with 80% power, we estimated that we would need at least 21 The study was approved both by the Washington University Human Research Protection Office and the University of Michigan Institutional Review Board.
RESULTS
We identified 337 patients with E. coli bacteriuria during the study period. Of these, 181 (54%) were excluded due to absence of blood cultures in the predetermined time window, leaving 156 patients with bacteriuria who had blood cultures drawn (Table 2) . Study patients were primarily female (n 5 111; 71%) and white (n 5 91; 58%); the median age was 66 (range, 19-98) years. Twenty-one (14%) patients were admitted from a long-term care facility. Most patients (n 5 103; 66%) had community-acquired bacteriuria. Forty-two (27%) had asymptomatic bacteriuria; 14 (9%) had cystitis; 70 (45%) had pyelonephritis (with or without cystitis); and 30 (19%) were labeled as having unclassified bacteriuria. Thirty-three (21%) patients had urinary catheterassociated bacteriuria (4 with cystitis, 11 with pyelonephritis, 9 with asymptomatic bacteriuria, and 9 with unclassified bacteriuria).
The median Charlson comorbidity index was 3 (range, 0-12) with the most frequent comorbidities being diabetes mellitus (37%), malignancy (27%), and renal insufficiency (26%). Among 111 female patients, 3 (3%) were peripartum. In 45 male patients, 12 (27%) had a diagnosis of benign prostatic hyperplasia, and 5 (11%) had a history of prostatic carcinoma. Sixty-nine (44%) subjects had records indicating $1 previous UTI. The median McCabe severity-of-illness score was 1 (range, 1-3). Fourteen (9%) patients died during hospital admission.
Patient Risk Factors for USB
Twenty-four of 156 subjects (15%) had E. coli bacteremia. Bacteremic patients were more likely than nonbacteremic patients to have a history of benign prostatic hyperplasia ( 
Bacterial Virulence Factors in USB
Overall, the most frequently detected virulence genes were ompT (132; 85%), chuA (132; 85%), fyuA (130; 83%), and yjaH (122; ; P , .001). We did not examine the effect of antibiotic selection as part of this analysis; however, the time from bacteriuria to appropriate antibiotics was shorter in bacteremic (median, 2 hours vs 5 hours; P 5 .02) than in nonbacteremic patients.
DISCUSSION
Escherichia coli bacteriurias are a first step toward kidney infection and USB. Here, we report findings from a prospective cohort of patients with E. coli bacteriuria at a tertiary care hospital, where we identified novel patient characteristics and bacterial virulence traits predictive for concurrent bacteriuria and USB. The strongest clinical predictors of bacteremia were hesitancy/retention symptoms in men and sex-independent urogenital surgery history. Group II capsule (kpsMT) was found more frequently among urinary isolates from individuals with bacteremia.
Previously, the only patient characteristic associated with USB was older age [6, 10] . Age was not associated with USB in this cohort, but symptoms of hesitancy and/or urinary retention at the time of bacteriuria were independent predictors among men. This has not been reported previously; but urinary retention is a known risk factor for developing a UTI in men [23, 24] . It is possible that longer exposure to bacteria not only increases the risk of local infection but also the risk of urothelial invasion. A history of benign prostatic hyperplasia also was associated with USB among men. Benign prostatic hyperplasia is thought to predispose to UTIs [25] . Further, the bacterial virulence factors required to colonize a structurally altered prostate may increase the risk of febrile UTIs [26] .
Among men and women in this cohort, a past history of urogenital surgery was associated with USB. We found no other reports of this association in the literature. Iatrogenic modification of the urogenital tract might lead to impaired urinary passage or voiding and increased infection risk. Conversely, patients with preexisting voiding difficulties may have been more likely to require surgery in the first place. Ikaheimo et al reported that bacteremic patients were more likely to have a ''compromising condition,'' which by their definition included urological abnormalities [7] . Of note, we found no association with bacteremia in patients who had developed bacteriuria after a urogenital procedure during the same admission.
Several relatively small studies (#100 isolates) have attempted to identify virulence factors that predict bacteremic progression by uropathogenic E. coli; almost all found P-fimbriae subtypes to play a role [5, 10, 27] . Other virulence determinants were not consistently associated with USB [8, 27] . Although prf was associated with an almost 2-fold increase in USB in univariate analysis of our cohort, it did not remain statistically significant after adjustment for hesitancy/retention and history of urogenital surgery. In contrast to these previous studies, ours is the first to report an association of kpsMT with USB risk in adults. A previous study among adults found no association with kpsMT [8] , but a study among male infants identified the K1 antigen (detected by antiserum tests) either alone or together with the hly genotype as predictive for USB [28] . The kpsMT genes direct polysialic acid capsule antigen K1 synthesis [29] , which was first identified in invasive E. coli strains [30] . K1 has been proposed to allow intracellular E. coli to evade lysis by preventing lysosomal fusion [31] . The kpsMT gene does not, however, detect K1 specifically but rather all group II K antigens; expression studies targeting K1 could be crucial in the next analytical step.
Increasing gram-negative antibiotic resistance has renewed interest in antivirulence therapeutic approaches [32] . In E. coli, K1 has been considered as a target for antivirulence compounds [33] . Assuming a higher prevalence of capsule antigen K1 expression in uropathogens with high bacteremic potential, a vaccine directed against capsule or epitopes extending beyond the capsule surface may be protective against USB. Indeed, cell surface vaccine candidates masked by capsule may be ineffective at preventing bacteremia [34] .
Another interesting finding is the high prevalence of the Yersinia high-pathogenicity island (ie, fyuA) in 88% of USB isolates. FyuA has been shown to be more frequent in symptomatic urinary isolates (89%-94%) than in fecal, colonizing strains (30%-47%) and has emerged from Bayesian network analysis as a close correlate to the clinical presentation [35, 36] . These findings suggest this high-pathogenicity island as another reasonable target for a virulence-directed therapeutic.
Some authors have demonstrated that USB is a useful indicator of increased disease severity and postulated that its identification can help shape management [37] . Other studies have questioned the need for blood cultures and the benefit of diagnosing bacteremia in women with pyelonephritis [38, 39] , presumably because outcomes were similar. Although we saw no mortality difference between bacteremic and nonbacteremic patients in our study, there were differences in management (eg, greater likelihood to be transferred to the ICU and shorter time to appropriate antibiotics for bacteremic patients) that may account for not seeing a difference in outcomes in this inpatient population. This goes also for variability in antibiotic choice, which we did not correct for in our outcomes analysis. Our findings differ from previous studies that only observed deaths in bacteremic patients [37, 40] .
There are a number of limitations to our study. First, it was conducted at a tertiary care center, and the findings may not be generalizable to other settings. Because inclusion required a physician-ordered blood culture, septic or febrile bacteriuric patients at risk for bacteremia may have been missed. More than half of the potentially eligible population was excluded because no blood cultures were ordered. Because greater severity of illness may have prompted a blood culture, it is possible that our nonbacteremic comparator group exhibits more similarities to the USB group than if all bacteriuric patients had been included. This may have diminished our ability to detect associations between patient characteristics, E. coli virulence factors, and USB. Symptoms at the time of bacteriuria were taken from hospital charts entered by physicians and nurses; patient symptoms may have been missed or not recorded. If recording of symptoms was associated with USB, it would bias our associations away from the null hypothesis. Lastly, although we started with the assumption that E. coli bacteremia is secondary to a urinary source, the close temporal relationship between isolates could also be consistent with ''descending'' infection of the urinary tract from the bloodstream.
In summary, our study is the largest cohort study to analyze both patient and pathogen factors associated with USB and the first to be conducted prospectively and include both sexes as well as community-and hospital-acquired bacteriuria. Novel risk factors (history of urogenital surgery, symptoms of hesitancy/ retention, presence of the bacterial kpsMT gene) that could serve as clinical predictors and lead to the development of novel diagnostic tests and treatments were identified.
Notes
